Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Soleno Therapeutics, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Soleno Therapeutics, Inc. is a biopharmaceutical company developing treatments for rare diseases. The company focuses on Prader-Willi syndrome, a genetic disorder causing chronic hunger, developmental issues, and metabolic problems. Soleno is advancing its lead candidate through clinical trials to address the unmet medical needs of patients with this rare condition.